Stay updated on Fruquintinib in Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-19T05:24:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-11T21:11:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-28T13:26:25.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T00:16:28.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a clinical trial for metastatic colorectal cancer and the addition of a new version number. The name of the study director has also been updated.
    Difference
    26%
    Check dated 2025-04-22T18:14:38.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The web page has been updated to reflect new timelines and methodologies related to the analysis of adverse events and efficacy of fruquintinib, including changes in the definitions of treatment-emergent adverse events (TEAEs) and the duration of study drug administration. Additionally, the revision number has been updated to v2.14.4.
    Difference
    14%
    Check dated 2025-04-08T09:26:41.000Z thumbnail image

Stay in the know with updates to Fruquintinib in Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.